News Updates
June 5, 2023
Intellia Therapeutics Announces Retirement of Jean-François Formela, M.D. From its Board of Directors
Learn More
May 31, 2023
Intellia Therapeutics to Present Updated Interim Data from Ongoing Phase 1/2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the EAACI Hybrid Congress 2023
Learn More
Powered by Juicer